Ardent Health Partners, Inc. (ARDT)
NYSE:ARDT
Want to see ARDT full AI Analyst Report?
ARDT Stock Chart & Stats
$9.91
$0.02(0.12%)
At close: 4:00 PM EST
$9.91
$0.02(0.12%)
Day’s Range― - ―
52-Week Range$8.07 - $15.48
Previous CloseN/A
Volume15.92K
Average Volume (3M)407.60K
Market Cap
$1.42B
Enterprise Value$2.02B
Total Cash (Recent Filing)$709.60M
Total Debt (Recent Filing)$2.26B
Price to Earnings (P/E)7.6
Beta0.59
Next Earnings
Aug 19, 2026EPS Estimate
0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.97
Shares Outstanding143,350,040
10 Day Avg. Volume333,763
30 Day Avg. Volume407,603
Financial Highlights & Ratios
PEG Ratio-0.23
Price to Book (P/B)0.74
Price to Sales (P/S)0.20
P/FCF Ratio4.81
Enterprise Value/Market Cap1.42
Enterprise Value/Revenue0.32
Enterprise Value/Gross Profit0.33
Enterprise Value/Ebitda4.02
Forecast
1Y Price Target
$12.70Price Target Upside28.15% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering10
EPS Forecast (FY)1.12
Revenue Forecast (FY)$6.57B
Bulls Say, Bears Say
Bulls Say
Cost ReductionCompany's IMPACT cost-savings program is reducing reliance on contract labor and tightening the cost structure, supporting improved operating leverage and potential margin expansion.
Margin ImprovementRealized cost savings are lifting margins and enabled reported profits to exceed expectations despite weaker revenue, creating an earnings tailwind.
Technology AdoptionBroad deployment of AI-powered ambient scribes is cutting clinician documentation time and improving coding accuracy, enhancing operational efficiency and revenue capture.
Bears Say
Exchange Subsidy HeadwindExpiration of enhanced exchange subsidies is expected to reduce enrollment and lower utilization, pressuring patient volumes and worsening payor mix.
Guidance ShortfallGuidance that came in below consensus signals softer revenue and profit expectations than peers, increasing downside risk to the stock.
Leverage And Reimbursement RiskHigh leverage on the balance sheet could limit financial flexibility while persistent reimbursement pressures weigh on earnings and strategic options.
Ardent Health Partners, Inc. News
ARDT FAQ
What was Ardent Health Partners, Inc.’s price range in the past 12 months?
Ardent Health Partners, Inc. lowest stock price was $8.07 and its highest was $15.48 in the past 12 months.
What is Ardent Health Partners, Inc.’s market cap?
Ardent Health Partners, Inc.’s market cap is $1.42B.
When is Ardent Health Partners, Inc.’s upcoming earnings report date?
Ardent Health Partners, Inc.’s upcoming earnings report date is Aug 19, 2026 which is in 103 days.
How were Ardent Health Partners, Inc.’s earnings last quarter?
Ardent Health Partners, Inc. released its earnings results on May 05, 2026. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.191 by $0.089.
Is Ardent Health Partners, Inc. overvalued?
According to Wall Street analysts Ardent Health Partners, Inc.’s price is currently Undervalued.
Does Ardent Health Partners, Inc. pay dividends?
Ardent Health Partners, Inc. does not currently pay dividends.
What is Ardent Health Partners, Inc.’s EPS estimate?
Ardent Health Partners, Inc.’s EPS estimate is 0.25.
How many shares outstanding does Ardent Health Partners, Inc. have?
Ardent Health Partners, Inc. has 143,350,040 shares outstanding.
What happened to Ardent Health Partners, Inc.’s price movement after its last earnings report?
Ardent Health Partners, Inc. reported an EPS of $0.28 in its last earnings report, beating expectations of $0.191. Following the earnings report the stock price went down -7.502%.
Which hedge fund is a major shareholder of Ardent Health Partners, Inc.?
Currently, no hedge funds are holding shares in ARDT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ardent Health Partners, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$12.70 (28.15% Upside)
$12.70 (28.15% Upside)
Hedge Fund Trend
Increased
By 1.3M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.0%
Last 30 Days ▼ 9.1%
Last 30 Days ▼ 9.1%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-24.97%
12-Months-Change
Fundamentals
Return on Equity
9.08%
Trailing 12-Months
Asset Growth
6.95%
Trailing 12-Months
Company Description
Ardent Health Partners, Inc.
Ardent Health Partners, LLC owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, LLC is a subsidiary of EGI-AM Investments, L.L.C.
ARDT Company Deck
ARDT Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed predominantly positive operational and financial momentum: solid top-line growth (+7% revenue), strong adjusted EBITDA improvement (+26%, or +15% excluding a one-time investment gain), meaningful margin expansion (110 bps), demonstrable cost and labor discipline (contract labor down >40%, SW&B per AA improvements), and healthy liquidity and leverage metrics. Management acknowledged near-term volume headwinds from weather and lighter flu, exchange-related revenue pressure (~$35M estimated headwind), higher professional fees and medical malpractice premium increases, and ongoing denial-management work. On balance, the positive execution against the IMPACT program, margin gains, cash/liquidity strength, and disciplined growth initiatives outweigh the noted challenges.View all ARDT earnings summariesARDT Stock 12 Month Forecast
Average Price Target
$12.70
▲(28.15% Upside)
Technical Analysis
Acadia Healthcare
―
Brookdale Senior Living
―
National Healthcare
―
Select Medical
―
Aveanna Healthcare Holdings
―
Ownership Overview
2.68% Insiders
3.53% Mutual Funds
0.22% Other Institutional Investors
90.95% Public Companies and
Individual Investors